384 related articles for article (PubMed ID: 35744957)
1. Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.
Asrorov AM; Muhitdinov B; Tu B; Mirzaakhmedov S; Wang H; Huang Y
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744957
[TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy.
Min KA; Maharjan P; Ham S; Shin MC
Arch Pharm Res; 2018 Jun; 41(6):594-616. PubMed ID: 29804279
[TBL] [Abstract][Full Text] [Related]
3. Laminin-derived peptides: Applications in drug delivery systems for targeting.
Negishi Y; Nomizu M
Pharmacol Ther; 2019 Oct; 202():91-97. PubMed ID: 31158392
[TBL] [Abstract][Full Text] [Related]
4. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Anti-cancer Protein/Peptide Delivery.
Liu X; Wu F; Ji Y; Yin L
Bioconjug Chem; 2019 Feb; 30(2):305-324. PubMed ID: 30428665
[TBL] [Abstract][Full Text] [Related]
6. Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
Chen Y; Zhang M; Min KA; Wang H; Shin MC; Li F; Yang VC; Huang Y
Curr Drug Targets; 2018 Feb; 19(4):380-392. PubMed ID: 28260497
[TBL] [Abstract][Full Text] [Related]
7. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
8. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.
Brown KC
Curr Pharm Des; 2010; 16(9):1040-54. PubMed ID: 20030617
[TBL] [Abstract][Full Text] [Related]
9. Improved pharmacokinetic characteristics and bioactive effects of anticancer enzyme delivery systems.
Yan S; Yang L; Lu L; Guo Q; Hu X; Yuan Y; Li Y; Wu M; Zhang J
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):951-960. PubMed ID: 30058385
[TBL] [Abstract][Full Text] [Related]
10. Peptide and protein drug delivery to and into tumors: challenges and solutions.
Torchilin VP; Lukyanov AN
Drug Discov Today; 2003 Mar; 8(6):259-66. PubMed ID: 12623240
[TBL] [Abstract][Full Text] [Related]
11. Smart Drug-Delivery Systems for Cancer Nanotherapy.
Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
[TBL] [Abstract][Full Text] [Related]
12. Polymer-Mediated Penetration-Independent Cancer Therapy.
Ding J; Feng X; Jiang Z; Xu W; Guo H; Zhuang X; Chen X
Biomacromolecules; 2019 Dec; 20(12):4258-4271. PubMed ID: 31668061
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems.
Ilangala AB; Lechanteur A; Fillet M; Piel G
Eur J Pharm Biopharm; 2021 Oct; 167():140-158. PubMed ID: 34311093
[TBL] [Abstract][Full Text] [Related]
14. Potential application of peptides in tumor targeting and anticancer therapeutics.
Prakash J
Curr Pharm Biotechnol; 2011 Aug; 12(8):1087-8. PubMed ID: 21470147
[No Abstract] [Full Text] [Related]
15. Marine-derived drugs: Recent advances in cancer therapy and immune signaling.
Saeed AFUH; Su J; Ouyang S
Biomed Pharmacother; 2021 Feb; 134():111091. PubMed ID: 33341044
[TBL] [Abstract][Full Text] [Related]
16. Cancer-targeted delivery systems based on peptides.
Chatzisideri T; Leonidis G; Sarli V
Future Med Chem; 2018 Sep; 10(18):2201-2226. PubMed ID: 30043641
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs.
Dubowchik GM; Walker MA
Pharmacol Ther; 1999 Aug; 83(2):67-123. PubMed ID: 10511457
[TBL] [Abstract][Full Text] [Related]
19. Development of peptides as potential drugs for cancer therapy.
Li ZJ; Cho CH
Curr Pharm Des; 2010; 16(10):1180-9. PubMed ID: 20166989
[TBL] [Abstract][Full Text] [Related]
20. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
